Menu

The Journey From Features To Compound Identification In Metabolomics: When Will We Get There?

In this eBook, learn about advancements in untargeted metabolomic workflow, including improved standards, guidelines, databases, and more!

Jul 13, 2018
The Scientist Creative Services Team

A relatively new field on the rise, metabolomics is breaking ground identifying metabolites, giving a better understanding of what has happened and is happening within an organism. One roadblock to this research is the bottleneck of untargeted metabolites which all but prevents biological interpretation. However, thanks to a concerted effort among researchers, metabolomics is seeing gains in compound identification through improved reporting standards, better instrumentation, in silico advancements, and data interpretation guidelines.

Download this eBook from The Scientist to find out more about: 
• Data Reduction Strategies
• Guidelines for Compound Identification
• Advancement of Databases and Libraries
• Untargeted Metabolomics Workflow
• Problems with Standards • Structural Elucidation Strategies

This free eBook was made possible by an educational grant from Thermo Fisher Scientific.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.